Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Harvard Business School
McKinsey
McKesson
Moodys

Last Updated: June 29, 2022

CLINICAL TRIALS PROFILE FOR AMPHETAMINE SULFATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Amphetamine Sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00218348 ↗ Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo Completed National Institute on Drug Abuse (NIDA) Phase 2 2003-09-01 Dextro-amphetamine sulfate is a central nervous system stimulant that increases the release of the neurotransmitter dopamine in the brain. The purpose of this study is to further examine dose ranges of dextro-amphetamine sulfate as a treatment for cocaine dependence.
NCT00218348 ↗ Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo Completed The University of Texas Health Science Center, Houston Phase 2 2003-09-01 Dextro-amphetamine sulfate is a central nervous system stimulant that increases the release of the neurotransmitter dopamine in the brain. The purpose of this study is to further examine dose ranges of dextro-amphetamine sulfate as a treatment for cocaine dependence.
NCT00248092 ↗ Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse Completed New River Pharmaceuticals Phase 1/Phase 2 2006-01-01 This research is being done to evaluate if NRP104 is a safe drug. The other purpose is to learn if NRP104 produces a high and any other effects like amphetamine and other stimulant drugs that are abused. This information will give some indication if NRP104 can be abused. NRP104 is an investigational drug. This means that it has not been approved by the U.S. Food and Drug Administration (FDA). Healthy people, between the ages of 18 and 55 with histories of substance abuse that include stimulant drugs, may join. Amphetamines are drugs that are used most often to treat attention deficit hyperactivity disorder (ADHD) in children, to treat narcolepsy (excessive sleepiness) and for weight loss.
NCT00715520 ↗ Neurobiological Principles Applied to the Rehabilitation of Stroke Patients Completed National Institute of Neurological Disorders and Stroke (NINDS) N/A 2007-04-01 The purpose of this study is to use (Transcranial Magnetic Stimulation) TMS or drugs to improve learning of movement skills and the adaptation processes in patients after stroke. Once investigators have determined the improving effect of TMS and the drugs on learning of movement skills, the study team may be able to provide information that improves rehabilitative treatment and helps to improve recovery after stroke.
NCT00715520 ↗ Neurobiological Principles Applied to the Rehabilitation of Stroke Patients Completed National Institutes of Health (NIH) N/A 2007-04-01 The purpose of this study is to use (Transcranial Magnetic Stimulation) TMS or drugs to improve learning of movement skills and the adaptation processes in patients after stroke. Once investigators have determined the improving effect of TMS and the drugs on learning of movement skills, the study team may be able to provide information that improves rehabilitative treatment and helps to improve recovery after stroke.
NCT00715520 ↗ Neurobiological Principles Applied to the Rehabilitation of Stroke Patients Completed Emory University N/A 2007-04-01 The purpose of this study is to use (Transcranial Magnetic Stimulation) TMS or drugs to improve learning of movement skills and the adaptation processes in patients after stroke. Once investigators have determined the improving effect of TMS and the drugs on learning of movement skills, the study team may be able to provide information that improves rehabilitative treatment and helps to improve recovery after stroke.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Amphetamine Sulfate

Condition Name

Condition Name for Amphetamine Sulfate
Intervention Trials
ADHD 2
Narcolepsy 2
Amphetamine-Related Disorders 1
Attention Deficit Disorder With Hyperactivity 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Amphetamine Sulfate
Intervention Trials
Attention Deficit Disorder with Hyperactivity 3
Hyperkinesis 3
Narcolepsy 2
Disease 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Amphetamine Sulfate

Trials by Country

Trials by Country for Amphetamine Sulfate
Location Trials
United States 24
Canada 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Amphetamine Sulfate
Location Trials
Texas 3
Nevada 2
Florida 2
Georgia 2
Utah 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Amphetamine Sulfate

Clinical Trial Phase

Clinical Trial Phase for Amphetamine Sulfate
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Amphetamine Sulfate
Clinical Trial Phase Trials
Completed 6
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Amphetamine Sulfate

Sponsor Name

Sponsor Name for Amphetamine Sulfate
Sponsor Trials
Arbor Pharmaceuticals, Inc. 2
Vallon Pharmaceuticals, Inc. 2
National Institute on Drug Abuse (NIDA) 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Amphetamine Sulfate
Sponsor Trials
Industry 5
NIH 4
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Express Scripts
McKinsey
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.